Lin Matthew J., Dubin Danielle P., Schwarcz Robert M., Khorasani Hooman
J Drugs Dermatol. 2019 Dec 1;18(12):1281.
Non-invasive procedures targeting the submental fat or “double chin” have undergone a surge in popularity. Injections of deoxycholic acid, a secondary bile acid, have recently received FDA-approval for fat reduction in this area. With appropriate patient selection, this preparation of 10 mg/mL of sodium deoxycholate (Kybella®, Kythera Biopharmaceuticals, Westlake Village, CA) leads to aesthetic improvement of moderate-to-severe convexity or fullness associated with submental fat in adults.
针对颏下脂肪或“双下巴”的非侵入性手术越来越受欢迎。注射脱氧胆酸(一种次级胆汁酸)最近已获得美国食品药品监督管理局(FDA)批准用于该区域的脂肪减少。通过适当选择患者,这种10mg/mL的脱氧胆酸钠制剂(Kybella®,Kythera生物制药公司,加利福尼亚州西湖村)可改善成人中与颏下脂肪相关的中度至重度凸起或丰满的外观。